Page 2 - Test PDF v5
P. 2
« Back to Contents
LiFE re
Literature for ENYGO
Preface
Dear colleagues,
this is the third consecutive edition of the LiFE report, containing reviews of publications in gynaecological oncology from November 15, 2015 -
February 15, 2016. LiFE is an initiative of ENYGO supported by ESGO.
This edition covers more topics than previous reports; it contains 38 separate reports. The quality of the included reports has also improved signif-
icantly over time and we would like to acknowledge the continuous work and effort from each author. We would also like to give special thanks to
all the authors who have agreed to cover additional topics. In addition, some new authors have joined the team – welcome!
The LiFE team is very grateful for the support of Beth Green in proofreading and also of our graphic designer Tomas Grünwald, who has designed a
new logo and layout for this edition – we hope you like it.
To assist us in preparing future editions of the report, the LiFE team and Dr Jan Boostels, who is also working with the Belgian branch of the Dutch
Cochrane Center (CEBAM), are preparing two webinars for LiFE authors. The first will focus on the development of an efficient literature search
strategy and the second on the critical appraisal of medical literature. We will be in touch with details soon.
Also, from this issue forward, the LiFE report will be published under a Creative Commons 4.0 License (CC BY-NC-ND 4.0). This does not change
the fact that the LiFE reports are free, ready to download and share.
We hope you will enjoy the third edition and find it interesting! Please let us know if you have any comments or other feedback.
And, if you are interested in becoming an author for LiFE, please get in touch and send us an email to enygo.life.project@esgomail.org.
Stay up to date!
Yours,
The LiFE team
Kristina Lindemann
Kamil Zalewski
Michael J. Halaska
Creative Commons license
LiFE reports are freely available to read, download and share from the time of publication. Reports are published under the terms of the Creative
Commons License Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) which allows readers to disseminate and reuse
the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works
without specific permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-nc-nd/4.0/
International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 2